#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    X-linked lymphoproliferative syndrome Tuberous sclerosis complex Subdural haematoma Medullary thyroid cancer Arteriosclerosis HER2 mutant non-small cell lung cancer Hepatic angiosarcoma Renal transplant Mycobacterium abscessus infection Meningococcal immunisation Glycogen storage disease type II Depression Diffuse large B-cell lymphoma Orthostatic hypotension Small cell lung cancer limited stage More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Life with Disease Breast angiosarcoma – Diagnostics Haemophagocytic lymphohistiocytosis – Treatment Encephalitis autoimmune – Trials in Disease Brain stem glioma – Basic Information Pleural mesothelioma malignant – Diagnostics Adrenocortical carcinoma – Diagnostics Brain stem glioma Mucopolysaccharidosis I – Life with Disease Brain stem glioma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bexotegrast Tovinontrine Valproic Acid Messenger Rna Encoding Cas9 Aflibercept Lovo-B Specific Nucleic Acid Sna-Her2 Io103 Acetate Xanomeline Tartrate CYCLIZINE HYDROCHLORIDE Decitabine Piperacillin Donidalorsen Sufentanil Plasma Metyrapone Bp Levocetirizine Dihydrochloride Crizanlizumab Amphotericin B Trabectedin More therapies…

    Learn about Your Condition

    Dedifferentiated liposarcoma Hepatobiliary cancer Metastatic gastric cancer Vasospasm Friedreich's ataxia Haemorrhagic stroke Lichen planopilaris Hepatic fibrosis Colorectal cancer stage II Dizziness Dementia Sickle cell disease Meningococcal infection Alveolar bone defect Major depression More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of sufentanil versus midazolam for pain relief during egg retrieval in women undergoing fertility treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Sufentanil
    • Diclofenac Sodium
    • Alprazolam
    Belgium

  • A study comparing 68Ga-FAPI-46 PET scan with standard 18F-FDG PET scan and brain MRI for staging in patients with newly diagnosed non-small cell lung cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    • Fludeoxyglucose (18F)
    The Netherlands

  • Study of abemaciclib and its connection to severe diarrhea in patients with hormone receptor-positive breast cancer at high risk of return

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Abemaciclib
    France

  • A Study of Watchful Waiting After Chemotherapy and Radiotherapy Compared to Surgery for Patients with Early Rectal Cancer Using Capecitabine

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Capecitabine
    Sweden

  • A Study of Blinatumomab in Children with Relapsed or Treatment-Resistant B Cell Acute Lymphoblastic Leukemia with Remaining Disease Traces

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Blinatumomab
    France Italy The Netherlands

  • Testing the effectiveness and safety of remimazolam, ketamine, and propofol for rapid sequence induction in patients at risk of aspiration

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Ketamine
    • Remimazolam
    • Propofol
    France
Previous Page
1 … 754 755 756 757 758 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!